EZ Debride Signs Distribution Agreement with BMK Ventures
by Industry News
Schertz, TX – March 13, 2018 – EZ Debride®, a registered and patent pending brand of MDM Wound Ventures LLC, developed and manufactured out of Schertz, Texas and Millersburg, Pennsylvania, is announcing the distribution agreement with BMK Ventures, Virginia Beach, Virginia.
"BMK Ventures is excited to spearhead sales, distribution and contract management for the EZ Debride to various branches of the US Military, Veterans Administration and Federal Government. BMK Ventures is a VETS FIRST, Certified, Service Disabled Veteran Owned Business, founded by a team of military medical personnel and industry specialists which prides itself in making the procurement process easier. We look forward to reaching and educating potential customers on this innovative tool." Ken Mullins, VP of Sales, BMK Ventures.
BMK Ventures (BMKV) is a SDVOB, based in Virginia Beach, VA.
EZ Debride is the next generation in sharp debridement. Designed by a surgeon, EZ Debride is a simple to use, sharp debridement instrument that can allow clinicians, with little or no prior debridement experience, to confidently and precisely debride wound patients. Designed to provide an easy, rapid and disposable option to debride wounds, EZ Debride will quickly become a valuable instrument that can be used by any wound care specialist.
“Partnering with BMK Ventures allows EZ Debride’s availability into the DoD, Federal Government and Veterans Administration’s facilities, which is very important to our mission and growth. They have the expertise and contract vehicles needed for easy procurement in these areas. We are excited to have them aboard,” states Derek Denton, CEO, EZ Debride.
About the Company
MDM Wound Ventures, LLC is the manufacturer of EZ Debride®. For more information about EZ Debride or MDM Wound Ventures LLC, or to book a clinical visit and demonstration please contact: email@example.com or visit www.ezdebride.com.
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies